NCT01461772View on ClinicalTrials.gov

Efficacy and Safety Study of Concurrent Chemoradiation Therapy to Treat Locally Advanced Cervical Cancer

PHASE3TerminatedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Cervical Cancer
Interventions
RADIATION

Radiation therapy

pelvic radiation therapy (Extended filed radiation therapy and addition of brachytherapy is allowed)

DRUG

Carboplatin

carboplatin 130mg/m2BSA on day 1,8,15,22,29,and 36

DRUG

Cisplatin

Cisplatin 40mg/m2BSA on day 1,8,15,22,29,and 36

Trial Locations (1)

138-736

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
collaborator

Boryung Pharmaceutical Co., Ltd

INDUSTRY

lead

Asan Medical Center

OTHER